Find similar products:
This medicinal product is subject to additional monitoring. This will allow quick identification of new safety information.
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PLGB 00242/0648.
Spravato 28 mg nasal spray, solution
Spravato 28 mg nasal spray, solution
Esketamine
▼This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
1. What Spravato is and what it is used for
2. What you need to know before you use Spravato
3. How to use Spravato
4. Possible side effects
5. How to store Spravato
6. Contents of the pack and other information
Spravato contains the active substance esketamine. This belongs to a group of medicines called anti-depressants and you have been given this medicine to treat your depression.
Spravato is used in adults to reduce the symptoms of depression, such as, feeling sad, anxious, or worthless, sleeping difficulties, change in appetite, loss of interest in favourite activities, feeling of being slowed down. It is given, together with another antidepressant, if you have tried at least 2 other antidepressant medicines but they have not helped.
Spravato is also used in adults to rapidly reduce symptoms of depression in a situation requiring immediate treatment (also known as a psychiatric emergency).
Do not use Spravato if any of the above apply to you. If you are not sure, talk to your doctor before using Spravato - your doctor will decide whether or not you can use this medicine.
Talk to your doctor before using Spravato if you have:
If any of the above apply to you (or you are not sure), talk to your doctor before using Spravato. Your doctor will decide whether you should use this medicine.
Tell your doctor or go to the nearest hospital straight away if you have thoughts of harming or killing yourself at any time.
You may find it helpful to talk to a relative or a close friend if you are depressed and ask them if they think your depression is getting worse or if they are worried about your behaviour. You might ask them to read this leaflet.
Spravato can increase your blood pressure for about 1 to 2 hours after you use it so your blood pressure will be measured before you start using Spravato and after using it.
If your blood pressure is high before using this medicine, your doctor will decide whether to start the medicine or wait until your blood pressure is lower. If your blood pressure goes up after using this medicine and stays high for more than a few hours, you may need to have some more tests.
This medicine may cause a temporary increase in your blood pressure after taking a dose. Your blood pressure will be checked before and after using this medicine. Tell the medical staff right away if you get chest pain, shortness of breath, sudden severe headache, change in vision, or seizures (fits) after using this medicine.
Tell your doctor if you get any of the above while you are taking Spravato.
If you are elderly (>65 years), you will be carefully monitored as you may be at increased risk of falling when you start moving around after treatment.
Do not give this medicine to children and adolescents younger than 18 years of age. This is because Spravato has not been studied for treatment-resistant depression in this age group.
Tell your doctor if you are taking, have recently taken or might take any other medicines.
Using Spravato with certain medicines may cause side effects. Especially tell your doctor if you take:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor for advice before using this medicine.
Contraception
If you are able to become pregnant you must use contraception during treatment. Talk with your doctor about suitable methods of contraception.
Pregnancy
Do not use Spravato if you are pregnant.
If you become pregnant while being treated with Spravato, talk to your doctor straight away – to decide whether to stop treatment and to learn about other options for treatment.
Breast-feeding
Do not use Spravato if you are breast-feeding. Talk to your doctor before using Spravato if you are breast-feeding. Your doctor will discuss with you whether to stop breast-feeding or stop using this medicine. Your doctor will take into account the benefit of breast-feeding for you and your child, and the benefit of treatment for you.
Spravato can make you feel sleepy, dizzy, and have other side effects that can temporarily affect your ability to drive vehicles or use machines and do activities that need you to be completely alert. After being treated with this medicine, do not take part in these activities until the next day following a restful sleep.
Always use this medicine exactly as your doctor has told you. Check with your doctor if you are not sure.
You will use the Spravato nasal spray yourself - under the supervision of your doctor or other healthcare professional in a healthcare setting, such as, the doctor’s office or clinic.
Your doctor or other healthcare professional will show you how to use the nasal spray device (see also Instructions for use).
Your doctor will decide if you need 1, 2 or 3 nasal spray devices and how often you should go to the doctor’s office or clinic for the medicine.
If your treatment is continued:
During and after each use of this medicine, your doctor will check you and decide how long to monitor you.
Some patients using Spravato may experience nausea or vomiting. You should avoid eating for 2 hours before treatment and not drinking liquids for 30 minutes before using this medicine.
If you need steroid or decongestant medicines as a nasal spray, avoid using them during the hour before your Spravato treatment.
You will use this medicine under the supervision of your doctor in the doctor’s office or clinic. Therefore, it is unlikely that you will use too much.
If you use too much Spravato, you are more likely to get side effects (see “Possible side effects”).
It is important to make sure you come in for your scheduled appointments, so that this medicine is effective for you.
If you have any further questions on the use of this medicine, ask your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Tell your doctor if you notice any of the following side effects.
Very common (may affect more than 1 in 10 people)
Common (may affect up to 1 in 10 people)
Uncommon (may affect up to 1 in 100 people)
Rare (may affect up to 1 in 1,000 people)
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and the label. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is esketamine.
Each nasal spray device contains esketamine hydrochloride corresponding to 28 mg esketamine.
The other ingredients are:
Citric acid monohydrate
Disodium edetate
Sodium hydroxide (for pH adjustment)
Water for injections
Spravato is a nasal spray solution. This medicine is a clear, colourless solution, provided in a single-use nasal spray device.
Spravato is available in pack sizes containing 1, 2, 3, or 6 nasal spray devices.
Each nasal spray device is individually packaged in a sealed blister.
Not all pack sizes may be marketed.
For information in large print, tape, CD or Braille, telephone 0800 7318450.
This leaflet was last revised in October 2024